Alexey Fayzullin, MD, Ph.D., is a Principal Investigator at the Department of Experimental Morphology and Biobanking at the leading national life science institute, Sechenov University (Moscow, Russia) since 02/2018. In his role, Alexey curates biomedical projects providing high-end morphological and molecular analyses (IHC, WB, PCR). Currently, his research efforts are dedicated to the development of computational pathology software and clinical biophotonics: 2022 "Peri-implant targeting - a new technological platform for gene therapy" (Russian Science Foundation, 300 000 USD) 2021 "Investigation of histological biomarkers of glioblastoma heterogeneity using neural network and Big Data technologies: a pilot study" (Russian Science Foundation, 50 000 USD) Dr. Fayzullin was granted a highly competitive Russian Scholarship for Studying Abroad (27000 USD) twice, which he used to support his research projects at Macquarie University and University of New South Wales (Sydney, Australia) from 07/2018 to 09/2019. His Ph.D. project on the development of antifibrotic scaffolds was supported by Russian Foundation for Basic Research and Innovation Promotion Foundation. Dr. Fayzullin is a co-author of 21 publications in SCOPUS peer-reviewed journals, of which 12 are published in Q1 journals, and the author of an invention patent.